Cross Country Healthcare (CCRN) Tops Q2 EPS by 19c

Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of $0.16, $0.19 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $216.8 million versus the consensus estimate of $198.89 million.

GUIDANCE:

Cross Country Healthcare sees Q3 2020 EPS of ($0.06)-($0.02), versus the consensus of ($0.01). Cross Country Healthcare sees Q3 2020 revenue of $170-180 million, versus the consensus of $194.7 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• Lucid reports Q2 output, names new CFO and five other leaders
• Rivian raises 2026 delivery outlook after Q2 results top guidance
• Kraken Robotics closes $615M Covelya acquisition, raises 2026 outlook